Vous n'êtes pas connecté
Microbot Medical's (MBOT) latest patient enrollment in its pivotal human clinical trial is expected to support the future submission to the FDA for the commercialization of the LIBERTY system.
Business Wire India CorFlow Therapeutics AG (CorFlow), a pioneering company in the field of cardiac care targeting microvascular disease, today...
Business Wire India CorFlow Therapeutics AG (CorFlow), a pioneering company in the field of cardiac care targeting microvascular disease, today...
Business Wire India GAMMAGARD LIQUID ERC [immune globulin infusion (human)] with Less Than or Equal to 2 µg/mL IgA in a 10% Solution is Approved...
Neurizon Therapeutics has announced progress to lift a US Food and Drug Administration (FDA) clinical hold on its lead drug ...
EMVision updates progress on its pivotal trial supporting FDA de novo clearance for the emu brain scanner and its continuous ...
Hands-on clinical training, mentorship from SGU faculty and alumni, and admissions insights inspire Africa’s future physicians St. George’s...
Integra enrolls first pediatric patient in AERA registry to evaluate real-world use of its ETBD system and expand ENT market presence.
HINGHAM, Mass., July 08, 2025 (GLOBE...
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Multiple System Atrophy pipeline constitutes 20+ key companies...